Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Carter

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Reports|November 27, 2025
Potentiation of noncanonical NF-κB signaling and marginal zone B cell expansion by CARD11-mediated regulation of p100 processingAnushka Ghosh, Tyler A Jones, Sophie Mackinnon, et al.
Blood|February 8, 2012
IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunityGiang T Tran, Suzanne J Hodgkinson, Nicole M Carter, et al.
Science Immunology|March 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8<sup>+</sup> T cell activation via the CARD11 signalosomeNicole M Carter, Wihib D Hankore, Yong-Kang Yang, et al.
Scientific Reports|November 24, 2017
Transcription factor NF-κB is modulated by symbiotic status in a sea anemone model of cnidarian bleachingKatelyn M Mansfield, Nicole M Carter, Linda Nguyen, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports|November 27, 2025
Potentiation of noncanonical NF-κB signaling and marginal zone B cell expansion by CARD11-mediated regulation of p100 processingAnushka Ghosh, Tyler A Jones, Sophie Mackinnon, et al.
Blood|February 8, 2012
IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunityGiang T Tran, Suzanne J Hodgkinson, Nicole M Carter, et al.
Science Immunology|March 14, 2025
QRICH1 mediates an intracellular checkpoint for CD8<sup>+</sup> T cell activation via the CARD11 signalosomeNicole M Carter, Wihib D Hankore, Yong-Kang Yang, et al.
Scientific Reports|November 24, 2017
Transcription factor NF-κB is modulated by symbiotic status in a sea anemone model of cnidarian bleachingKatelyn M Mansfield, Nicole M Carter, Linda Nguyen, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Pageof 2